Pattern of Visual Analog Score Changes in Metastatic Urogenital Cancer Patients Undergoing Sympathectomy
DOI:
https://doi.org/10.51601/ijhp.v4i4.357Abstract
This study aimed to evaluate the effectiveness of sympathectomy in reducing pain in patients with metastatic urogenital cancer. A single-blind randomized clinical trial involving five patients who underwent neurolytic ganglion impar block using a transcoccygeal approach, followed by radiofrequency ablation (RFA), was conducted. Five patients with metastatic urogenital cancer, averaging 58.4 ± 16.9 years old, showed a significant reduction in pain after sympathectomy. The average Visual Analog Scale (VAS) reduction was 2 points on the first day, 4 points on the third day, and 5 points on the fifth day. This pain reduction was accompanied by a decrease in the patients' dependence on opioid medication. Sympathectomy and radiofrequency ablation have proven effective in reducing pain in patients with metastatic urogenital cancer. These findings support the use of sympathectomy as part of comprehensive pain management in metastatic cancer patients, improving quality of life and reducing opioid usage. This approach offers a promising alternative for managing chronic pain in this patient population, particularly when oral therapy is insufficient.
References
M. A. König, S. Jehan, G. Balamurali, M. Bierschneider, A. Grillhösl, and B. M. Boszczyk, “Kyphoplasty For Lytic Tumour Lesions of The Spine: Prospective Follow-Up of 11 Cases From Procedure to Death,” Eur. Spine J., vol. 21, no. 9, pp. 1873–1879, Sep. 2012, doi: 10.1007/s00586-012-2264-5.
C. Johanes, R. A. Monoarfa, R. I. Ismail, and R. Umbas, “Anxiety Level of Early and Late Stage Prostate Cancer Patients,” Prostate Int., vol. 1, no. 4, pp. 177–182, Dec. 2013, doi: 10.12954/PI.13027.
S. Catt, L. Matthews, S. May, H. Payne, M. Mason, and V. Jenkins, “Patients and Partners Views of Care and Treatment Provided For Metastatic Castrate‐Resistant Prostate Cancer in The UK,” Eur. J. Cancer Care (Engl)., vol. 28, no. 6, Nov. 2019, doi: 10.1111/ecc.13140.
X. Zhou et al., “Altered Functional Connectivity in Pain-Related Brain Regions and Its Correlation with Pain Duration in Bone Metastasis with Cancer Pain,” Dis. Markers, vol. 2022, pp. 1–9, Aug. 2022, doi: 10.1155/2022/3044186.
R. K. Mahaseth, R. Pun, and K. Shrestha, “Management of Pain with Morphine in cancer patients in a Tertiary Care Centre of Nepal,” Nepal Med. Coll. J., vol. 23, no. 3, pp. 210–215, Oct. 2021, doi: 10.3126/nmcj.v23i3.40379.
Y. Kohada et al., “Novel Quantitative Software for Automatically Excluding Red Bone Marrow on Whole‐Body Magnetic Resonance Imaging in Patients with Metastatic Prostate Cancer: A Pilot Study,” Int. J. Urol., vol. 30, no. 4, pp. 356–364, Apr. 2023, doi: 10.1111/iju.15124.
R. Angioli et al., “Effectiveness of CO 2 Laser on Urogenital Syndrome in Women With a Previous Gynecological Neoplasia: A Multicentric Study,” Int. J. Gynecol. Cancer, vol. 30, no. 5, pp. 590–595, May 2020, doi: 10.1136/ijgc-2019-001028.
B. Pirnia, K. Pirnia, M. Teimouri, and P. Kolahi, “Acupuncture for Back Pain in Colon Cancer: A Case Report,” Int. J. Cancer Manag., vol. 10, no. 12, Dec. 2017, doi: 10.5812/ijcm.15087.
C. M. Donati et al., “Adequacy of Pain Treatment in Radiotherapy Departments: Results of a Multicenter Study on 2104 Patients (Arise),” Cancers (Basel)., vol. 14, no. 19, p. 4660, Sep. 2022, doi: 10.3390/cancers14194660.
M.-M. Mihailescu-Marin, D. V. Mosoiu, and L. Dima, “Comprehensive Targeted Treatment for Neuropathic and Nociceptive Pain in Palliative Care Patients,” Am. J. Ther., vol. 29, no. 5, pp. e512–e519, Sep. 2022, doi: 10.1097/MJT.0000000000001536.
S. N. Raja et al., “The Revised International Association For The Study of Pain Definition of Pain: Concepts, Challenges, and Compromises,” Pain, vol. 161, no. 9, pp. 1976–1982, Sep. 2020, doi: 10.1097/j.pain.0000000000001939.
M. F. Yam, Y. C. Loh, C. S. Tan, S. Khadijah Adam, N. Abdul Manan, and R. Basir, “General Pathways of Pain Sensation and the Major Neurotransmitters Involved in Pain Regulation,” Int. J. Mol. Sci., vol. 19, no. 8, p. 2164, Jul. 2018, doi: 10.3390/ijms19082164.
A. Jemal, M. M. Center, C. DeSantis, and E. M. Ward, “Global Patterns of Cancer Incidence and Mortality Rates and Trends,” Cancer Epidemiol. Biomarkers Prev., vol. 19, no. 8, pp. 1893–1907, Aug. 2010.
G. Das, Penatalaksanaan Nyeri. Jakarta: EGC, 2019.
K. Upadhya R, L. Shenoy, and R. Venkateswaran, “Effect of Intravenous Dexmedetomidine Administered as Bolus or As Bolus-Plus-Infusion on Subarachnoid Anesthesia with Hyperbaric Bupivacaine,” J. Anaesthesiol. Clin. Pharmacol., vol. 34, no. 3, pp. 46–50, 2018, doi: 10.4103/joacp.JOACP.
J. Y. Kim, S. E. Sim, S. Yoo, M. Joo, and H. J. Park, “A New Technique of Ganglion Impar Pulsed Radiofrequency Ablation,” Chin. Med. J. (Engl)., vol. 134, no. 10, pp. 1221–1223, May 2021.
Y. Q. Zhou et al., “Interleukin-6: An Emerging Regulator of Pathological Pain,” J. Neuroinflammation, vol. 13, no. 1, pp. 1–9, 2016, doi: 10.1186/s12974-016-0607-6.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Dicky Panduwinata, Maximillian Ch Oley, Eko Prasetyo
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
